SETPOINT MEDICAL BIOELECTRONIC THERAPY IS AN ENTIRELY NEW APPROACH TO TREAT DISEASE AT THE SOURCE

The SetPoint Medical bioelectronic medicine platform delivers targeted electrical pulses to trigger the intrinsic inflammatory reflex. This pathway shows promise as an alternative, efficient treatment option for rheumatoid arthritis (RA), Crohn’s disease, and other chronic autoimmune diseases – that may reduce risk, lower cost and improve patient adherence to therapy.

SetPoint_bioelectronic_medicine_therapy_platform

THREE COMPONENTS, ONE INTEGRATED PLATFORM

SetPoint Medical’s novel, proprietary bioelectronic platform consists of an implantable MicroRegulator, a wireless charging collar and iPad-based prescription application.

The system works together to activate the innate inflammatory reflex to produce a systemic anti-inflammatory effect and to help regulate the immune system.

CLINICAL STUDIES IN RHEUMATOID ARTHRITIS AND CROHN'S DISEASE ONGOING, WITH ROBUST PIPELINE TO FOLLOW

Bioelectronic medicine provides an alternative treatment option for a range of autoimmune conditions without the significant side effects of immunosuppression typically associated with conventional therapies.

SetPoint Medical has focused this new therapeutic approach for debilitating conditions first on rheumatoid arthritis (RA), Crohn’s disease and multiple sclerosis (MS).

SetPoint bioelectronic medicine therapy patient success

THE PATIENT EXPERIENCE

Bioelectronic medicine to treat chronic autoimmune diseases has already undergone initial proof-of-concept clinical studies using
an off-the-shelf vagus nerve stimulator.